APIPHARM

APIPharm is specialized in the distribution of active pharmaceutical ingredients of plant origin including semi-synthetic cannabinoid isolates and the development of advanced pharmaceutical formulations. APIPharm identified the niche for high quality pharma grade active pharmaceutical ingredients that can be integrated in final products by pharmaceutical industry. APIpharm supplies high quality active pharmaceutical ingredients with all required documentation and GMP analitics... APIPharm was established in 2020 by Dr. Matevz Pompe, the SWISS BIOTEC Group and Michael Bigl, CEO of the swiss OSIRIS Global Holding AG. All partners are experts in the area of high quality pharma analytics and Syntehesis... Specialised for specific API tradewith focus on quality. APIPharm is registered as wholesale company of active pharmaceutical ingredients.

Also known as: APIPharm d.o.o.